Terms: = Colorectal cancer AND BCL9L, BCL9-2, 283149, ENSG00000186174, DLNB11
18 results:
1. β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon cancer.
Suzuki T; Kilbey A; Casa-Rodríguez N; Lawlor A; Georgakopoulou A; Hayman H; Yin Swe KL; Nordin A; Cantù C; Vantourout P; Ridgway RA; Byrne RM; Chen L; Verzi MP; Gay DM; Gil Vázquez E; Belnoue-Davis HL; Gilroy K; Køstner AH; Kersten C; Thuwajit C; Andersen DK; Wiesheu R; Jandke A; Blyth K; Roseweir AK; Leedham SJ; Dunne PD; Edwards J; Hayday A; Sansom OJ; Coffelt SB
Cancer Immunol Res; 2023 Aug; 11(8):1137-1155. PubMed ID: 37309673
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
Yadav P; Sharma P; Chetlangia N; Mayalagu P; Karunagaran D
Chem Biol Interact; 2022 Dec; 368():110224. PubMed ID: 36272469
[TBL] [Abstract] [Full Text] [Related]
3. Whole exome sequencing of a gut-associated lymphoid tissue neoplasm points to precursor or early form of sporadic colon carcinoma.
Yaseen A; Ladenheim A; Olson KA; Libertini SJ; McPherson JD; Matsukuma K
Pathol Res Pract; 2021 Apr; 220():153406. PubMed ID: 33740545
[TBL] [Abstract] [Full Text] [Related]
4. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells.
Kishore C; Sundaram S; Karunagaran D
Chem Biol Interact; 2019 Aug; 309():108725. PubMed ID: 31238027
[TBL] [Abstract] [Full Text] [Related]
5. miR-22 and miR-214 targeting bcl9l inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract] [Full Text] [Related]
6. Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.
Xicola RM; Manojlovic Z; Augustus GJ; Kupfer SS; Emmadi R; Alagiozian-Angelova V; Triche T; Salhia B; Carpten J; Llor X; Ellis NA
Carcinogenesis; 2018 Dec; 39(11):1331-1341. PubMed ID: 30239619
[TBL] [Abstract] [Full Text] [Related]
7. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
8. bcl9l Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in colorectal cancer.
López-García C; Sansregret L; Domingo E; McGranahan N; Hobor S; Birkbak NJ; Horswell S; Grönroos E; Favero F; Rowan AJ; Matthews N; Begum S; Phillimore B; Burrell R; Oukrif D; Spencer-Dene B; Kovac M; Stamp G; Stewart A; Danielsen H; Novelli M; Tomlinson I; Swanton C
Cancer Cell; 2017 Jan; 31(1):79-93. PubMed ID: 28073006
[TBL] [Abstract] [Full Text] [Related]
9. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.
Mohammadi M; Salmasi Z; Hashemi M; Mosaffa F; Abnous K; Ramezani M
Int J Pharm; 2015 May; 485(1-2):50-60. PubMed ID: 25712164
[TBL] [Abstract] [Full Text] [Related]
10. MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of β-catenin in human colorectal cancer cells.
Subramanian M; Rao SR; Thacker P; Chatterjee S; Karunagaran D
J Cell Biochem; 2014 Nov; 115(11):1974-84. PubMed ID: 24913975
[TBL] [Abstract] [Full Text] [Related]
11. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
Raghu D; Karunagaran D
J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
[TBL] [Abstract] [Full Text] [Related]
12. LEF1 and B9L shield β-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.
de la Roche M; Ibrahim AE; Mieszczanek J; Bienz M
Cancer Res; 2014 Mar; 74(5):1495-505. PubMed ID: 24419084
[TBL] [Abstract] [Full Text] [Related]
13. bcl9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract] [Full Text] [Related]
14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract] [Full Text] [Related]
15. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
Toya H; Oyama T; Ohwada S; Togo N; Sakamoto I; Horiguchi J; Koibuchi Y; Adachi S; Jigami T; Nakajima T; Akiyama T
Cancer Sci; 2007 Apr; 98(4):484-90. PubMed ID: 17309600
[TBL] [Abstract] [Full Text] [Related]
17. bcl9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Hoffmans R; Basler K
Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
[TBL] [Abstract] [Full Text] [Related]
18. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
Katoh M; Katoh M
Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
[TBL] [Abstract] [Full Text] [Related]
